Showing results (21-30 of 45) with videos related to
Sort By:
Pageof 5
Therapeutic Drug Monitoring|June 1, 1995
Optimized method for determination of gabapentin in serum by high-performance liquid chromatographyG L Lensmeyer, T Kempf, B E Gidal, et al.The Annals of Pharmacotherapy|January 12, 2000
Vigabatrin: a novel therapy for seizure disordersB E Gidal, M D Privitera, R D Sheth, et al.Journal of Clinical Pharmacy and Therapeutics|August 1, 1995
Relationship between valproic acid dosage, plasma concentration and clearance in adult monotherapy patients with epilepsyB E Gidal, M E Pitterle, N W Spencer, et al.Epilepsia|January 1, 1994
Lorazepam-valproate interaction: studies in normal subjects and isolated perfused rat liverG D Anderson, B E Gidal, E D Kantor, et al.Epilepsia|April 1, 1996
Evaluation of carbamazepine and carbamazepine-epoxide protein binding in patients undergoing epilepsy surgeryB E Gidal, N W Spencer, M M Maly, et al.Epilepsy Research|April 1, 1997
Lamotrigine pharmacokinetics in patients receiving felbamateB E Gidal, A Kanner, M Maly, et al.Epilepsy Research|September 21, 2000
Lack of an effect of valproate concentration on lamotrigine pharmacokinetics in developmentally disabled patients with epilepsyB E Gidal, G D Anderson, P R Rutecki, et al.The Annals of Pharmacotherapy|March 1, 1997
Effects of aspirin on platelet aggregation in smokers and nonsmokersC Chant, S C Fagan, S K Aurora, et al.Therapeutic Drug Monitoring|February 1, 1995
Evaluation of a potential enantioselective interaction between ticlopidine and warfarin in chronically anticoagulated patientsB E Gidal, C A Sorkness, K A McGill, et al.Epilepsy Research|June 23, 2000
Inter- and intra-subject variability in gabapentin absorption and absolute bioavailabilityB E Gidal, L L Radulovic, S Kruger, et al.Pageof 5